Crescent Biopharma CBIO
NASDAQ CBIO
$13.92 +0.27 (+1.98%)
At close: Nov 10, 2026 · 4:00 PM EST

Crescent Biopharma (CBIO) Other Operating Expenses (2024 - 2026)

Updated

Crescent Biopharma (CBIO) posted Other Operating Expenses of $19.39 million for Q2 2026, up 76.2% from $11.01 million a year earlier and up 8.3% from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Other Operating Expenses (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Other Operating Expenses at Crescent Biopharma was $152.67 million, up 346.1% year-over-year; for FY2025, it came in at $135.9 million, up 880.5% from FY2024.

  • Annual Other Operating Expenses shows a five-year compound annual growth rate of 24.8% (FY2020 to FY2025).
  • In prior years, Crescent Biopharma's Other Operating Expenses was $13.86 million in FY2024 (-30.9%), $20.07 million in FY2023 (-29.3%), $28.39 million in FY2022 (-40.2%) and $47.49 million in FY2021 (+5.7%).
  • Quarterly Other Operating Expenses has run from a low of $1.72 million in Q3 2024 to a high of $95.03 million in Q4 2025 over five years.
  • On a year-over-year basis, Other Operating Expenses has increased in each of the last three quarters, with growth averaging 149.9% over the last seven quarters.
  • The strongest year-over-year quarter for Other Operating Expenses in the past five years was Q4 2025, with growth of 693.1%; the weakest was Q3 2024, with a decline of 67.6%.
  • According to Business Quant data, Other Operating Expenses for the three prior quarters was $17.9 million (Q1 2026), $95.03 million (Q4 2025) and $20.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Crescent Biopharma 418.60 Mn -288.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.77 Mn
Dec 31, 2024 -2.02 Mn
API Access

Crescent Biopharma Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=CBIO&period=max&api_key=YOUR_API_KEY